Stone Ridge Asset Management’s ResMed RMD Stock Holding History

Stone Ridge Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,148	Closed	-$412K	–	387
2020 Q2	$412K	Sell	2,148 -1,606	-43%	-$263K	0.07%	329
2020 Q1	$553K	Sell	3,754 -800	-18%	-$127K	0.06%	356
2019 Q4	$706K	Hold	4,554	–	–	0.04%	515
2019 Q3	$615K	Buy	4,554 +800	+21%	+$105K	0.04%	591
2019 Q2	$458K	Hold	3,754	–	–	0.03%	760
2019 Q1	$390K	Sell	3,754 -13,808	-79%	-$1.43M	0.02%	813
2018 Q4	$2M	Buy	17,562 +4,265	+32%	+$457K	0.12%	169
2018 Q3	$1.53M	Buy	13,297 +3,593	+37%	+$394K	0.08%	277
2018 Q2	$1M	Buy	9,704 +2,503	+35%	+$253K	0.06%	417
2018 Q1	$709K	Buy	7,201 +900	+14%	+$85K	0.04%	571
2017 Q4	$534K	Buy	+6,301	New	+$521K	0.03%	772

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stone Ridge Asset Management's RMD Position: Q3 2020 in Review

Stone Ridge Asset Management sold out of ResMed (RMD) in Q3 2020, closing a stake of 2,148 shares — an estimated $412K sold.

Stone Ridge Asset Management first reported a position in RMD in Q4 2017 and held it in 11 quarters. The position peaked at $2M in Q4 2018. 626 funds tracked by Wall St. Rank hold RMD as of Q3 2020.

Stone Ridge Asset Management reported no remaining ResMed position as of Q3 2020 after selling out during the quarter.
Stone Ridge Asset Management sold 2,148 ResMed shares in Q3 2020, an estimated $412K.
Stone Ridge Asset Management first reported a position in ResMed in Q4 2017 and held it in 11 quarters.
Stone Ridge Asset Management's ResMed position peaked at $2M in Q4 2018.
626 funds tracked by Wall St. Rank held ResMed as of Q3 2020.

Based on Stone Ridge Asset Management's 13F filing for Q3 2020.